The GAD-7 is one of the most widely used anxiety questionnaires in the world, by doctors and psychologists alike. It measures how much anxiety symptoms have bothered you over the last two weeks.
It is not a diagnosis: it is a reference point, to put words and numbers to what you are going through. Only a professional can carry out a full assessment.
🔒 Your answers stay on your device: nothing is sent or stored.
Your result
This result is a reference point, not a diagnosis. It does not replace a professional's opinion.
What now?
If you are having suicidal thoughts or feel in danger: call 112 (emergency number in Europe), 3114 in France, or your local emergency number.
About this test
The GAD-7 (Generalized Anxiety Disorder-7) was developed by Drs Robert L. Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission is required to reproduce, translate, display or distribute it.
The cut-off points 5, 10 and 15 correspond to mild, moderate and severe anxiety. A score of 10 or more is the most widely used reference point for recommending a professional assessment.
Sources
- Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097. https://doi.org/10.1001/archinte.166.10.1092
- Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical Care, 46(3), 266-274. https://doi.org/10.1097/MLR.0b013e318160d093
- Plummer, F., Manea, L., Trepel, D., & McMillan, D. (2016). Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. General Hospital Psychiatry, 39, 24-31. https://doi.org/10.1016/j.genhosppsych.2015.11.005
- García-Campayo, J., Zamorano, E., Ruiz, M. A., Pardo, A., Pérez-Páramo, M., López-Gómez, V., Freire, O., & Rejas, J. (2010). Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health and Quality of Life Outcomes, 8, 8. https://doi.org/10.1186/1477-7525-8-8
- Micoulaud-Franchi, J.-A., Lagarde, S., Barkate, G., et al. (2016). Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Epilepsy & Behavior, 57, 211-216. https://doi.org/10.1016/j.yebeh.2016.02.015
- Pfizer Inc. PHQ and GAD-7 screeners and official translations. https://www.phqscreeners.com

